Pharma Symposium Canada 2015 is a conference dedicated to the dual challenges of market access and rising healthcare costs.
Key Topics
How Canada compares to other countries as a place for manufacturers to invest
Critical updates from the PMPRB
The increasing financial pressure and accountability both public and private payers are dealing with as they face greater scrutiny by taxpayers and plan sponsors
What challenges manufacturers have doing business in the Canadian marketplace
An update on Bill C-17 so you can assess and prepare your organization for its impact
What added benefits and challenges pharmacies bring to both patient management and market access strategies
What new business models could be considered concerning orphan drugs and specialty drug therapies
The latest developments and future plans for the pan-Canadian Pharmaceutical Alliance (pCPA)
Potential new areas of collaboration and market strategies
How personalized medicine could change the industry and payer benefit plans
Who should Attend
Attendees from:
Federal and Provincial Governments, Agencies, Boards and Commissions: Health Canada, Industry Canada, Competition Bureau, PMPRB, CADTH, Pan-Canadian Pricing Alliance (PCPA)
Pharmaceutical: Manufacturers, Distributors, Wholesalers (both Brand and generic)
Medical Community (academic and community hospitals)
Private health insurance (employee benefit programs)
Industry Associations: Rx&D, Canadian Generic Pharmaceutical Assoc. (CGPA, Canadian Assoc. for Healthcare Reimbursement (CAHR), Canadian Life and Health Insurance Assoc. (CLHIA), Canadian Assoc. for Pharmacy Distribution Management (CAPDM), Canadian Pharmacists Assoc. (CPA), Canadian Association of Chain Drug Stores (CACDS), Canadian Neighbourhood Pharmacy Assoc. of Canada (CACDS), Canadian Society of Hospital Pharmacists (CSHP), BIOTECanada
Large universities (research departments)
Drug retailers/pharmacists
Patient representatives and Non-profit agencies, eg. Canadian Cancer Society
